 "Prof V K Unni of IIM Calcutta")
The Indian pharmaceutical market which would rank amongst the top five in terms of volume is also the largest provider of generic drugs globally. This has earned India the sobriquet “pharmacy of the developing world”. It is estimated that Indian pharmaceutical companies supply around 80 per cent of the antiretroviral drugs that are being used on a global scale to deal with AIDS.
The sector, which is valued at around $ 35 billion, is expected to cross $ 50 billion by 2019-20. This sector also attracts considerable Foreign Direct Investment (FDI) with inflows crossing $ 13 billion during the last
